5 Best Blue Chip Stocks That Outperformed in 2022

2. Johnson & Johnson (NYSE:JNJ)

Year to Date Return as of December 13: 4.47%

Number of Hedge Fund Holders: 85

Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) shares have increased 4.47% year to date as the company continues to grow earnings. For the third quarter, Johnson & Johnson (NYSE:JNJ) earned an adjusted EPS of $2.55 on sales of $23.8 billion versus the consensus of $2.48 on revenue of $23.34 billion.

For FY22, Johnson & Johnson (NYSE:JNJ) sees adjusted EPS of $10.02 to $10.07 versus the prior view of $10.00 to $10.10.